Civatech Oncology
Durham
About Civatech Oncology
Civatech Oncology is a medical device company that develops polymer-based devices to treat cancer using localized low-dose-rate radiation. Because polymers are easy to manufacture in different shapes and formats, CivaTech's patented and patent-pending technology enables devices that can be designed and fabricated for specific tumor types. Its first product, the CivaString, has been granted FDA 510k clearance to treat any solid tumor. The company was founded in 2006 and is based in Durham, North Carolina, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.1M
- Last round: Grant (Aug 2023)
- Website: civatechoncology.com
- Phone: 919-314-5515
Industries & Categories
Biotechnology, Life Science, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/civatech-oncology-10936 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.